APWA
GILD icon

Atlas Private Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Atlas Private Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2
Closed -$1K – 688
2020
Q2 		$1K Buy
+2
New +$153 ﹤0.01% 657

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Atlas Private Wealth Advisors's GILD Position: Q3 2025 in Review

Atlas Private Wealth Advisors sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,564 shares — an estimated $395K sold.

Atlas Private Wealth Advisors first reported a position in GILD in Q2 2020 and held it in 11 quarters. The position peaked at $717K in Q4 2024. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Atlas Private Wealth Advisors reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 3,564 Gilead Sciences shares in Q3 2025, an estimated $395K.
  • Atlas Private Wealth Advisors first reported a position in Gilead Sciences in Q2 2020 and held it in 11 quarters.
  • Atlas Private Wealth Advisors's Gilead Sciences position peaked at $717K in Q4 2024.
  • 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Atlas Private Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.